Publications by authors named "S Pernas"

Claim this Profile
P
Palbociclib, trastuzumab and endocrine therapy in pretreated HER2-positive and PAM50 luminal advanced breast cancer: randomised phase II, SOLTI-1303 PATRICIA trial.
Eva Ciruelos, Tomás Pascual, Guillermo Villacampa, Sonia Pernas, Rodrigo Sanchez Bayona

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Datopotamab deruxtecan versus chemotherapy in previously treated inoperable/metastatic hormone-receptor-positive HER2-negative breast cancer: final overall survival analysis of the phase 3 TROPION-Breast01 study.
B Pistilli, K Jhaveri, S-A Im, S Pernas, M De Laurentiis

Ann Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SEOM-GEICAM-SOLTI clinical guidelines in advanced breast cancer (UPDATE 2025).
Jose Angel Garcia-Saenz, Isabel Blancas Lopez-Barajas, Isabel Echavarria, Carmen Hinojo Gonzalez, Mireia Margeli Vila, Sonia Pernas

Clin Transl Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-clinical trial targeting ER, FGFR and CDK4/6 in resistant hormone-positive breast cancer with FGFR alterations.
Noelia Martinez-Jañez, José Ángel García-Saenz, Sonia Pernas, Begoña Bermejo, Serafín Morales

NPJ Precis Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palbociclib and trastuzumab for HER2-positive metastatic breast cancer: final overall survival results of cohort A and B of SOLTI-1303-PATRICIA trial.
T Pascual, G Villacampa, M Oliveira, S Escrivá-de-Romaní, S Pernas

ESMO Open· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis